OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activated T cell-derived exosomes for targeted delivery of AXL-siRNA loaded paclitaxel-poly-L-lysine prodrug to overcome drug resistance in triple-negative breast cancer
Chuanrong Chen, Ming Shen, Xiaofeng Wan, et al.
Chemical Engineering Journal (2023) Vol. 468, pp. 143454-143454
Closed Access | Times Cited: 16

Showing 16 citing articles:

Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review
Zhen Chen, Min Xiong, Jiaqi Tian, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 36

Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
Young‐Jin Choi, Su Hyun Seok, Hong Yeol Yoon, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115306-115306
Open Access | Times Cited: 19

AXL signaling in cancer: from molecular insights to targeted therapies
Monika Yadav, Anuj K. Sharma, Ketki Patne, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2

Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer
Xiaohui Qian, Yang Huang, Ziqiang Ye, et al.
ACS Nano (2024) Vol. 18, Iss. 24, pp. 15864-15877
Closed Access | Times Cited: 8

Extracellular Vesicle‐Based Antitumor Nanomedicines
Mingfeng Li, Yanfei Liu, Fei Liu, et al.
Advanced Healthcare Materials (2025)
Closed Access

pH-responsive nanocomplex for active transport of aPD-1 and PTX to enhance cancer chemoimmunotherapy
Yating Qin, Yan Lin, Chao Tian, et al.
Nano Today (2025) Vol. 62, pp. 102710-102710
Closed Access

Recent progress in cancer immunotherapy: Application of nano-therapeutic systems
Robabehbeygom Ghafelehbashi, Mitra Salehi, Monireh Kouhi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105184-105184
Closed Access | Times Cited: 8

Immune cell-derived exosomes as promising tools for cancer therapy
Junge Chen, Gang Zhang, Yichen Wan, et al.
Journal of Controlled Release (2023) Vol. 364, pp. 508-528
Closed Access | Times Cited: 7

Dendritic polylysine co-delivery of paclitaxel and siAXL enhances the sensitivity of triple-negative breast cancer chemotherapy
Xiaofeng Wan, Chuanrong Chen, Jianmin Zhan, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 2

From conventional to cutting-edge: Exosomes revolutionizing nano-drug delivery systems
Huiyang Fu, Yinfeng Chen, Qingyao Fu, et al.
Chemical Engineering Journal (2024), pp. 156685-156685
Closed Access | Times Cited: 2

STAT3-specific nanocarrier for shRNA/drug dual delivery and tumor synergistic therapy
Le Sun, Jishang Sun, Cuiyao Li, et al.
Bioactive Materials (2024) Vol. 41, pp. 137-157
Open Access | Times Cited: 1

Decitabine/paclitaxel co-delivery systems modified with anti-PD-L1 antibodies mediate chemoimmunotherapy for Triple negative breast cancer
Yang He, Qin Hu, Liting Wang, et al.
Materials & Design (2023) Vol. 237, pp. 112562-112562
Open Access | Times Cited: 2

Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer
Jia-Xin Qiao, Dongyan Guo, Huan Tian, et al.
Materials Today Bio (2024) Vol. 29, pp. 101358-101358
Open Access

Page 1

Scroll to top